2026 NPPES data Specialist NPI 1154537017 M.D.
Verify on CMS →

MARK BRESCIA, M.D.

Specialist in HOBOKEN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
133
Medicare Part D claims · 29 beneficiaries · Specialist avg: 1K
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.9574/100
▲ 12 pts above national avg 83.1 · [object Object]
Industry payments
$120.24
6 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK BRESCIA, M.D. reported a CMS MIPS final score of 94.9574/100 — above the 83.1 national average — and filed 133 Medicare Part D claims in 2023.

94.9574/100
MIPS score · +12 vs avg
133
Part D claims, 2023
92%
generic prescribing
$120.24
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK BRESCIA, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 25% higher than 75% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about MARK BRESCIA, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 05/15/2007

NPI 1154537017

Primary specialty

Specialist

High-volume

69,658 US NPIs in this specialty

Medicare Part D claims

133 91% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

MIPS final score

94.9574/100 11.857400000000013% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New Jersey

How Specialist compares to other specialties among New Jersey providers

New Jersey providers

Specialist share within New Jersey

1. Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Specialist share within New Jersey

Medicare quality performance — MIPS

MARK BRESCIA, M.D.'s 2023 MIPS final score plotted against the Specialist national average

High performer (top quartile)
MIPS Final Score
94.9574/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Specialist) — 94.9574/100 vs national avg 83.1

0%100%National avg83%95%
MIPS final score (Specialist) — 94.9574/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BRESCIA, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 1131 WASHINGTON ST, HOBOKEN, NJ, 07030, with a listed phone of (201) 659-7700. NPI 1154537017 was issued on 05/15/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRESCIA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 133 prescription claims written by this provider, covering 29 Medicare beneficiaries and totaling roughly $10K in drug spend, split 8% brand-name and 92% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 94.9574/100 for the 2023 performance year (Quality 87.2651), compared with the national average of 83.1.

Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1131 WASHINGTON ST
HOBOKEN, NJ 07030

Provider Details

NPI 1154537017
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 05/15/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

94.9574
Final Score
Avg: 83.1
87.2651
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MARK BRESCIA, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

MEDICAL ASSOCIATES OF ENGLEWOOD PC
HARRINGTON PARK, NJ

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BRESCIA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$120

Largest payer

Organon Llc

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MARK BRESCIA, M.D. — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 133 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

133
Total Claims
$10K
Total Drug Cost
29
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
160
Total Day Supply
4,030
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$3K
Generic Drug Cost
$7K
Antibiotic Claims
21

Patient Demographics

Average Patient Age
72.1 years
Avg HCC Risk Score
1.13
Gender Split
100% female / 0% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK BRESCIA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Valacyclovir
Valacyclovir Hcl
16
Alprazolam
13
Clobetasol Propionate
13
Estradiol
13
Zolpidem Tartrate
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How MARK BRESCIA, M.D. fits within the Specialist landscape nationally.

69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

MARK BRESCIA, M.D.'s 133 claims are below the specialty average of 1,474.

Nearby Specialist Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as BRESCIA.

Compare Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BRESCIA, M.D.'s specialty?
MARK BRESCIA, M.D. specializes in Specialist and practices in HOBOKEN, New Jersey. Credentials: M.D..
How much does MARK BRESCIA, M.D. prescribe under Medicare Part D?
In 2023, MARK BRESCIA, M.D. wrote 133 Medicare Part D claims totaling $10K in drug costs for 29 beneficiaries.
What is MARK BRESCIA, M.D.'s Medicare quality score?
MARK BRESCIA, M.D. has a CMS MIPS Final Score of 94.9574/100 (Quality: 87.2651). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK BRESCIA, M.D. located?
MARK BRESCIA, M.D. is located at 1131 WASHINGTON ST, HOBOKEN, NJ, 07030. Phone: (201) 659-7700.
What is MARK BRESCIA, M.D.'s NPI number?
MARK BRESCIA, M.D.'s National Provider Identifier (NPI) is 1154537017, issued on 05/15/2007.
Does MARK BRESCIA, M.D. prescribe more brand-name or generic drugs?
MARK BRESCIA, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $3K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does MARK BRESCIA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK BRESCIA, M.D.'s most frequently prescribed drugs include Valacyclovir, Alprazolam, Clobetasol Propionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BRESCIA, M.D. accept Medicare?
MARK BRESCIA, M.D. appears in CMS Medicare data with 133 Part D claims and 29 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BRESCIA, M.D.'s credentials?
MARK BRESCIA, M.D.'s NPI is 1154537017 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology